Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spinal stimulation at home may boost arm strength in paralysis

NCT ID NCT07438353

Symptom relief Sponsor: Singapore General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a home-based digital rehabilitation program combined with a non-invasive spinal cord stimulation device to improve upper limb function in people with chronic tetraplegia. Nine participants will use a mobile app-guided exercise program with daily stimulation over 22 weeks. The goal is to see if this approach is safe, feasible, and effective for improving strength, sensation, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous spinal cord stimulation (tSCS) device
What this could lead to
If it works, this could offer a safe, home-based way to improve arm and hand function and quality of life for people with tetraplegia.
What could go wrong
This is a very small early study (9 people) with no control group, so results may not apply widely. The device may not provide meaningful improvement, and home use carries risks like skin irritation or falls.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 9 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participant * Age 21 -75 years; * Non-progressive cervical SCI/spinal cord dysfunction (traumatic or non-traumatic); * Duration of SCI/spinal cord dysfunction more than or equal to 12 months; * ASIA Impairment scale (AIS B, C, or D) with impaired upper limb function; * At least one hand capable of grasp and pinch, with or without assistive modification; * International Standards for Neurological Classification of Spinal Cord Injury-Upper Extremity Measurement Scale (ISNCSCI-UEMS) more than or equal to 20; * Able to maintain an upright sitting position for at least 30 minutes; * No contraindication for tSCS (e.g., no pacemakers or other implantable stimulators); * Motivated and able to engage in a daily home-based rehabilitation program; * Availability of a dedicated care-giver to set up digital home-based therapy program Caregiver * Age 21 -75 years; * As identified by the patient as the caregiver; * Willing to participate in the study Exclusion Criteria: Participant * Significant or unstable medical co-morbidities including uncontrolled cardiopulmonary disease, severe cognitive impairment, severe dysautonomia, as determined by the investigator; * Pregnancy; * History of other neurologic conditions affecting upper limb function, such as stroke, multiple sclerosis, or traumatic brain injury; * Known history of peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc); * Ongoing treatment for cancer; * Skin conditions or active cancerous lesion that limit the application of tSCS electrodes * Known contraindication for tSCS (pacemakers or other implantable stimulators); * Prior exposure to tSCS treatment; * Inability to provide informed consent. Caregiver: • Inability to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Quadriplegia/tetraplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

quadriplegia spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Quadriplegia/tetraplegia Spinal cord injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Singapore General Hospital

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.